Cypralis Limited
Research and experimental development on biotechnology · Cambridge
ActiveUnited KingdomIncorporated 2012Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 88 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2025-12-31
IXBRL · 88 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 49
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod223_4254_08028515_20251231
- Source archive
- Accounts_Bulk_Data-2026-07-02.zip
Accounts to 2025-12-31
IXBRL · 88 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2025-12-31
IXBRL · 88 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 49
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2607_08028515_20251231
- Source archive
- Accounts_Monthly_Data-July2026.zip
Accounts to 2024-12-31
IXBRL · 91 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2024-12-31
IXBRL · 91 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 52
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2509_08028515_20241231
- Source archive
- Accounts_Monthly_Data-September2025.zip
Accounts to 2023-12-31
IXBRL · 87 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 87 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 49
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2476_08028515_20231231
- Source archive
- Accounts_Monthly_Data-September2024.zip
Accounts to 2022-12-31
IXBRL · 90 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 90 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2022-01-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 50
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0024_08028515_20221231
- Source archive
- Accounts_Monthly_Data-August2023.zip
Registered details
08028515- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2012-04-12
- Jurisdiction
- —
- Registered office
- 1ST JOHNS INNOVATION CENTRE, COWLEY ROAD, CAMBRIDGE, CB4 0WS, ENGLAND
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
1 SH01-derived rounds2018-06-18
£335,700 raised
£3,602,555 estimated post-money
Research and innovation
4 matched grantsThe functional role of cyclophilins and the effect of cyclophilin inhibitors in coronavirus infectionBBSRC · Studentship · 2021-09-30 – 2025-09-29 · with 1 other participant£0whole project
The functional role of cyclophilins and the effect of cyclophilin inhibitors in coronavirus infection
BBSRC · Studentship · 2021-09-30 – 2025-09-29 · with 1 other participant
£0
whole project
University Of EdinburghleadCypralis Ltd
Cyclophilin Inhibitors for Chronic PancreatitisLeadInnovate UK · Feasibility Studies · 2017-08-01 – 2018-07-31 · with 1 other participant£71,087awarded
Cyclophilin Inhibitors for Chronic PancreatitisLead
Innovate UK · Feasibility Studies · 2017-08-01 – 2018-07-31 · with 1 other participant
£71,087
awarded
Cypralis Limitedlead£71,087
Selective Inhibitors of Cyclophilin D for the treatment of Acute PancreatitisLeadInnovate UK · Collaborative R&D · 2017-01-01 – 2017-12-31 · with 1 other participant£191,953awarded
Selective Inhibitors of Cyclophilin D for the treatment of Acute PancreatitisLead
Innovate UK · Collaborative R&D · 2017-01-01 – 2017-12-31 · with 1 other participant
£191,953
awarded
Cypralis Limitedlead£191,953
Selective inhibitors of cyclophilin D for the treatment of acute pancreatitisLead
Innovate UK · Feasibility Studies · 2015-10-01 – 2016-10-31
£119,996
awarded